Do Conflicting Analyst Calls On Carter’s (CRI) Reveal Deeper Uncertainty In Its Long‑Term Strategy?

Simply Wall St

Tue, February 24, 2026 at 11:14 AM GMT+9 3 min read

In this article:

CRI

-3.92%

UBS

-2.44%

C

-4.53%

In recent weeks, several major banks including UBS, Citigroup, and Goldman Sachs have updated their views on Carter's, revising ratings and expectations for the children's apparel company.

This cluster of differing analyst opinions, ranging from Neutral to Sell and Underweight through to more positive views, highlights growing debate over Carter's longer‑term outlook and risk profile.

We will now examine how this recent shift in analyst sentiment toward Carter's could influence the existing investment narrative for the company.

The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Carter’s Investment Narrative Recap

To own Carter’s today, you need to believe it can stabilize earnings after a difficult period, while continuing to leverage its baby focus, brand strength, and efficiency efforts. The recent cluster of analyst revisions, with UBS lifting its target and Citigroup moving to Buy, may support the near term share price, but does not materially change the core near term catalyst around margin recovery or the key risk of pressured profitability.

Against that backdrop, Carter’s ongoing commitment to regular dividends, including the affirmed US$0.25 quarterly payments through late 2025, matters for many shareholders. With earnings under pressure and one off losses affecting recent results, the dividend record gives a tangible data point on how management is balancing returning cash to investors with funding the investments needed to support any future rebound in margins and earnings.

Yet beneath the recent optimism, one issue investors should be watching very closely is…

Read the full narrative on Carter’s (it’s free!)

Carter’s narrative projects $2.8 billion revenue and $39.2 million earnings by 2028. This implies a 0.4% yearly revenue decline and an earnings decrease of $93.3 million from $132.5 million today.

Uncover how Carter’s forecasts yield a $33.40 fair value, a 22% downside to its current price.

Exploring Other Perspectives

CRI 1-Year Stock Price Chart

The most optimistic analysts once expected revenue near US$3,000,000,000 and earnings around US$108,200,000 by 2028, which is far more upbeat than the tariff and wholesale risks others focus on, and the latest shift in analyst sentiment could easily push either view to evolve from here.

Explore 4 other fair value estimates on Carter’s - why the stock might be worth as much as $33.40!

Decide For Yourself

Don’t just follow the ticker - dig into the data and build a conviction that’s truly your own.

Story Continues  

A great starting point for your Carter's research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.

Our free Carter's research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Carter's overall financial health at a glance.

Looking For Alternative Opportunities?

Our daily scans reveal stocks with breakout potential. Don’t miss this chance:

Outshine the giants: these 24 early-stage AI stocks could fund your retirement.

The latest GPUs need a type of rare earth metal called Dysprosium and there are only 30 companies in the world exploring or producing it. Find the list for free.

AI is about to change healthcare. These 27 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include CRI.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info